|
000
| 01656nam##2200289za#4500 |
|---|
| 001 | 9.615755 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615101254 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2001||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a0-662-31036-5 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-7/2001-11E |
|---|
| 110 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 245 | 10|aImidacloprid |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c2001. |
|---|
| 300 | |a10p. : |btables ; |c28 cm. |
|---|
| 490 | 1 |aRegulatory note |vREG 2001-11 |
|---|
| 500 | |a"This regulatory note provides a summary of decisions taken and the rationales for the regulatory decisions regarding these products. The ongoing assessment of data, including studies generated in Canada, has confirmed the inherent properties of imidacloprid as identified in the original assessment and supports the continued judicious approach taken by the PMRA to use expansions to the imidacloprid use pattern."--Page 1. |
|---|
| 520 | 3 |aThis regulatory note provides a summary of decisions taken and the rationales for the regulatory decisions regarding these products. The ongoing assessment of data, including studies generated in Canada, has confirmed the inherent properties of imidacloprid as identified in the original assessment and supports the continued judicious approach taken by the PMRA to use expansions to the imidacloprid use pattern.--Page 1 |
|---|
| 563 | |aSoftcover |
|---|
| 590 | |a01-38|b2001-09-21 |
|---|
| 690 | 07|aInsecticides|2gcpds |
|---|
| 775 | 08|tImidacloprid |w(CaOODSP)9.625779 |
|---|
| 776 | 0#|tImidacloprid |w(CaOODSP)9.572698 |
|---|
| 830 | #0|aRegulatory note ;|vREG 2001-11|w(CaOODSP)9.514702 |
|---|